HelicoreAlternative Names: Helicore
Latest Information Update: 28 Nov 2006
At a glance
- Originator Novavax
- Class Anti-infectives
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Helicobacter infections
Most Recent Events
- 23 Dec 1998 Preclinical development for Helicobacter infections in USA (PO)
- 03 Dec 1997 New profile
- 03 Dec 1997 Phase-II clinical trials for Helicobacter infections in USA (PO)